Skye Bioscience, Inc. (NASDAQ:SKYE) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Joel, and I will be your conference operator today.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | DAFNA Capital Management Nathan Fischel | 2,046.032 | $252,000 | -12% | 0.19% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$10.00 | 450,000 | $4,500,000.00 | 8,393,520 | 2024-03-13 | Filing | |
$2.31 | 5,206,074 | $12,026,030.94 | 7,943,520 | 2024-01-31 | Filing | |
$0.02 | 881,000 | $16,474.70 | 25,683,957 | 2023-08-29 | Filing | |
$0.02 | 881,000 | $16,474.70 | 41,554,828 | 2023-08-29 | Filing | |
$100,000.00 | 1,000,000 | $100,000,000,000.00 | 1,000,000 | 2020-08-07 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.42 | 6,470 | $22,127.40 | 57,493 | 2025-08-22 | Filing | |
$3.42 | 163,979 | $560,808.18 | 1,457,064 | 2025-08-22 | Filing | |
$3.57 | 2,314 | $8,260.98 | 63,963 | 2025-08-21 | Filing | |
$3.57 | 58,642 | $209,351.94 | 1,621,043 | 2025-08-21 | Filing | |
$3.42 | 6,470 | $22,127.40 | 57,493 | 2025-08-22 | Filing |